Archive – Multinational Companies

Roche’s new boss open to new acquisitions

This content was published on Sep 10, 2023 Swiss pharmaceuticals group Roche is not ruling out further acquisitions. But a major takeover must make scientific and financial sense.

VW owners affected by “Dieselgate” in Switzerland will not receive compensation

This content was published on Sep 10, 2023 The class action lawsuit filed in Germany by 2,000 owners of Volkswagen diesel vehicles with manipulated engines will be dropped without compensation.

Colombia puts the brakes on giant Glencore mine as water dries up

This content was published on Sep 9, 2023 Colombia's first leftist president aspires to halt the rush to extract raw materials and save the Amazon from the climate crisis.

Lundin case: a Swiss oil executive on trial for Sudan war crimes

This content was published on Sep 8, 2023 Two former bosses of Swedish oil firm Lundin, including Swiss former executive Alex Schneiter, are on trial for complicity in war crimes in Sudan.

SWISS introduces ‘green’ fare for domestic flights

This content was published on Sep 7, 2023 Swiss International Air Lines (SWISS) wants to advance its sustainability goals with increased fares for domestic flights.

Swiss luxury group Richemont sees inflation bite into demand

This content was published on Sep 7, 2023 The chairman of Richemont, the Swiss owner of luxury brands like Cartier, said inflation is starting to hit luxury demand in Europe.

Explainer: how vulnerable is Switzerland to cyber-attacks?

This content was published on Sep 5, 2023 Cyberattacks are a growing headache for governments and companies around the world. Switzerland is no exception.

Is there anything about food or farming that you’re concerned about?

There's so much choice when it comes to food shopping but deciding what to put in your food basket has become complicated.

Join the discussion

Sep 5, 2023

36 Comments

View the discussion

Food allergies can be deadly but also costly for those concerned

This content was published on Sep 2, 2023 The latest treatment for peanut allergy can cost around $10,000 a year and was supposed to be a pharma blockbuster. What went wrong?

Novartis blasts US move to rein in drug prices

This content was published on Sep 1, 2023 The Basel-based pharma giant has joined industry peers in criticising the US government’s plan to rein in drug prices.

Page 41 of 119

First … 39 40 41 42 43 … Last

Archive – Multinational Companies

Popular Stories

Most Discussed

Archive – Multinational Companies

More

Roche’s new boss open to new acquisitions

More

VW owners affected by “Dieselgate” in Switzerland will not receive compensation

More

Colombia puts the brakes on giant Glencore mine as water dries up

More

Lundin case: a Swiss oil executive on trial for Sudan war crimes

More

SWISS introduces ‘green’ fare for domestic flights

More

Swiss luxury group Richemont sees inflation bite into demand

More

Explainer: how vulnerable is Switzerland to cyber-attacks?

More

Is there anything about food or farming that you’re concerned about?

More

Food allergies can be deadly but also costly for those concerned

More

Novartis blasts US move to rein in drug prices

Popular Stories

Most Discussed